William Blair & Company
TRIB

William Blair & Company’s Trinity Biotech TRIB Stock Holding History

William Blair & Company’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,518
Closed -$324K – 1243
2015
Q4 		$324K Buy
5,518
+356
+7% +$21K ﹤0.01% 931
2015
Q3 		$295K Sell
5,162
-148,477
-97% -$11.9M ﹤0.01% 1148
2015
Q2 		$13.9M Sell
153,639
-365
-0.2% -$31.6K 0.02% 781
2015
Q1 		$14.8M Buy
154,004
+33,447
+28% +$3.09M 0.02% 723
2014
Q4 		$10.6M Buy
120,557
+1,509
+1% +$130K 0.02% 833
2014
Q3 		$10.9M Sell
119,048
-6,430
-5% -$696K 0.02% 806
2014
Q2 		$14.4M Sell
125,478
-3,491
-3% -$414K 0.02% 711
2014
Q1 		$15.6M Sell
128,969
-6,303
-5% -$826K 0.03% 660
2013
Q4 		$17M Sell
135,272
-38,093
-22% -$4.57M 0.03% 590
2013
Q3 		$18.9M Buy
173,365
+28,912
+20% +$2.82M 0.03% 524
2013
Q2 		$12.2M Buy
+144,453
New +$12M 0.02% 639

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

William Blair & Company's TRIB Position: Q1 2016 in Review

William Blair & Company sold out of Trinity Biotech (TRIB) in Q1 2016, closing a stake of 5,518 shares — an estimated $324K sold.

William Blair & Company first reported a position in TRIB in Q2 2013 and held it in 11 quarters. The position peaked at $18.9M in Q3 2013. 79 funds tracked by Wall St. Rank hold TRIB as of Q1 2016.

  • William Blair & Company reported no remaining Trinity Biotech position as of Q1 2016 after selling out during the quarter.
  • William Blair & Company sold 5,518 Trinity Biotech shares in Q1 2016, an estimated $324K.
  • William Blair & Company first reported a position in Trinity Biotech in Q2 2013 and held it in 11 quarters.
  • William Blair & Company's Trinity Biotech position peaked at $18.9M in Q3 2013.
  • 79 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2016.

Based on William Blair & Company's 13F filing for Q1 2016, filed 16 May 2016.